|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis显示文摘 | Ana-Carolina Cardoso Rami Moucari Claudio Figueiredo-Mendes Marie-Pierre Ripault Nathalie Giuily Corinne Castelnau Nathalie Boyer Tarik Asselah Michelle Martinot-Peignoux Sarah Maylin Roberto J. Carvalho-Filho Dominique Valla Pierre Bedossa Patrick Marcel | 2010 | Journal of Hepatology2010，，5： | 3 |
| 2 | <ce:link locator='fx1'/> <ce:link locator='fx2'/> Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis显示文摘 | Rami Moucari Tarik Asselah Dominique Cazals–Hatem Hélène Voitot Nathalie Boyer Marie–Pierre Ripault Rodolphe Sobesky Michèle Martinot–Peignoux Sarah Maylin Marie–Hélène Nicolas–Chanoine Valérie Paradis Michel Vidaud Dominique Valla Pierre Bedossa Patrick | 2008 | Gastroenterology2008，，2： | 2 |
| 3 | Insulin resistance and geographical origin:major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4显示文摘 | MOUCARE R RIPAULT MP MARTINOT-PEIGNOUX M | 2009 | Gut2009，58，12： | 1 |
| 4 | Impact of ribavirin dose on retreatment of chronic hepatitis C patients显示文摘AIM: To study the efficacy and factors associated with a sustained virological response (SVR) in chronic hepatitis C (CHC) relapsing patients. METHODS: Out of 1228 CHC patients treated with pegylated interferon (PEG-IFN) and ribavirin (RBV), 165 (13%) had a relapse. Among these, 62 patients were retreated with PEG-IFN-2a or-2b and RBV. Clinical, biological, virological and histological data were collected. Initial doses and treatment modifications were recorded. The efficacy of retreatment and predictive factors for SVR were analyzed. RESULTS: An SVR was achieved in 42% of patients. SVR was higher in young (< 50 years) (61%) than old patients (27%) (P = 0.007), and in genotype 2 or 3 (57%) than in genotype 1 or 4 (28%) patients (P = 0.023). Prolonging therapy for at least 24 wk more than the previous course was associated with higher SVR rates (53% vs 28%, P = 0.04). Also, a better SVR rate was observed with RBV dose/body weight > 15.2 mg/kg per day (70% vs 35%, P = 0.04). In logistic regression, predictors of a response were age (P = 0.018), genotype (P = 0.048) and initial RBV dose/body weight (P = 0.022). None of the patients without a complete early virological response achieved an SVR (negative predictive value = 100%). CONCLUSION: Retreatment with PEG-IFN/RBV is effective in genotype 2 or 3 relapsers, especially in young patients. A high dose of RBV seems to be important for the retreatment response. | Christiane Stern Michelle Martinot-Peignoux Marie Pierre Ripault Nathalie Boyer Corinne Castelnau Dominique Valla Patrick Marcellin | 2012 | World Journal of Gastroenterology2012，18，23： | 1 |
| 5 | Sequential therapywith adefovirdipivoxil and pegylated interferon alfa - 2a forHBeAg - negative patients显示文摘 | Moucari R Boyer N Ripault MP | 2011 | J Viral Hepat2011，18，8： | 1 |
| 6 | Chronic lymphoid leukemia secondarily associated with a malignant reticulopathy: richter syn- drome 显示文摘 | Lortholary P Boiron M Ripault P | 1964 | Nouv Rev Fr Hematol1964，4，： | 1 |
| 7 | The Current Status of Antiviral Therapy of Chronic Hepatitis B显示文摘 | ASSELAH T RIPAULT MP CASTELNAU C | 2005 | J Clin Virol(S1386-6532)2005，34，1： | 1 |
| 8 | The current status of antiviral therapy of chronic hepatitis B显示文摘 | Tarik Asselah Marie-Pierre Ripault Corinne Castelnau | 2005 | Journal of Clinical Virology2005，11，： | 1 |
| 9 | The current status of antiviral therapy of chronic hepatitis B显示文摘 | Asselah T Ripault M P Castelnau C | 2005 | J Clin Virol2005，34，1： | 1 |
| 10 | Insulin resistance and geographical origin:major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4显示文摘 | Moucari R Ripault MP Martinot-Peignoux M | 2009 | Gut2009，58，12： | 1 |
| 11 | <ce:link locator='fx1'/> <ce:link locator='fx2'/> Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis显示文摘 | Rami Moucari Tarik Asselah Dominique Cazals–Hatem Hélène Voitot Nathalie Boyer Marie–Pierre Ripault Rodolphe Sobesky Michèle Martinot–Peignoux Sarah Maylin Marie–Hélène Nicolas–Chanoine Valérie Paradis Michel Vidaud Dominique Valla Pierre Bedossa Patrick | 2008 | Gastroenterology2008，，2： | 1 |
| 12 | Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis显示文摘 | Rami Moucari Tarik Asselah Dominique Cazals–Hatem Hélène Voitot Nathalie Boyer Marie–Pierre Ripault Rodolphe Sobesky Michèle Martinot–Peignoux Sarah Maylin Marie–Hélène Nicolas–Chanoine Valérie Paradis Michel Vidaud Dominique Valla Pierre Bedossa Patrick | 2008 | Gastroenterology2008，，2： | 1 |
| 13 | IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C显示文摘 | Tarik Asselah Simon De Muynck Philippe Bro?t Julien Masliah-Planchon Maud Blanluet Ivan Bièche Martine Lapalus Michelle Martinot-Peignoux Olivier Lada Emilie Estrabaud Qian Zhang Ahmed El Ray Dominique Vidaud Marie-Pierre Ripault Nathalie Boyer Pierre Bed | 2011 | Journal of Hepatology2011，，3： | 1 |
| 14 | Sequential thera- py with adefovir dipivoxil and pegylated interferon alfa -2a for HBeAg -negative patients显示文摘 | MOUCARI R BOYER N RIPAULT MP | 2011 | J Viral Hepat2011，18，8： | 1 |
| 15 | Crizotinib-induced acute hepatitis: First case with relapse after reintroduction with reduced dose显示文摘 | Marie-Pierre Ripault Véronique Pinzani Véronique Fayolle Georges-Philippe Pageaux Dominique Larrey | 2012 | Clinics and Research in Hepatology and Gastroenterology2012，，： | 1 |
| 16 | Sequential therapy with adefovir dipivoxil and pegylated interferon alfa - 2a for NBeAg - negative patients 显示文摘 | MOUCARI R BOYER N RIPAULT MP | 2011 | J Viral Hepat2011，18，8： | 1 |
| 17 | Richter's syndrome显示文摘 | Lortholary P Ripault M Boiron M | 1964 | Nouv Rev Fr Hematol1964，72，： | 1 |
| 18 | Richter's Syndrome显示文摘 | Lortholary P Ripault M Boiron M | 1964 | Nouv Rev Fr Hematol1964，72，2： | 1 |
| 19 | Serum Proteome to Predict Virologic Response in Patients With Hepatitis C Treated by Pegylated Interferon Plus Ribavirin显示文摘 | Valérie Paradis Tarik Asselah Delphine Dargere Marie–Pierre Ripault Michèle Martinot Nathalie Boyer Dominique Valla Patrick Marcellin Pierre Bedossa | 2006 | Gastroenterology2006，，7： | 1 |
| 20 | Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa‐2a in HBeAg‐negative patients显示文摘 | Rami Moucari Vincent Mackiewicz Olivier Lada Marie‐Pierre Ripault Corinne Castelnau Michelle Martinot‐Peignoux Agnes Dauvergne Tarik Asselah Nathalie Boyer Pierre Bedossa Dominique Valla Michel Vidaud Marie‐Hélène Nicolas‐Chanoine Patrick Marcellin | 2009 | Hepatology2009，，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员